Tirzepatide
Dual GLP-1 / GIP receptor agonist
Dual GLP-1 / GIP receptor agonist for appetite control, glucose regulation, and sustained weight loss. Available in 10mg, 30mg, and 60mg vials.
Important Research Notice
Research use only. Not for human consumption. This product is intended solely for laboratory research and educational applications. It is not designed for use in the diagnosis, treatment, cure, or prevention of any disease or medical condition. By purchasing this product, you acknowledge that this product is intended for research use only and agree to use it in accordance with all applicable laws and regulations.
People also buy

5-Amino-1MQ
Metabolic support compound

Retatrutide 10mg
Retatrutide injectable

Tesamorelin
Growth hormone releasing factor analog

BPC-157
Recovery peptide

CJC-1295 (without DAC)
Growth hormone secretagogue peptide

CJC-1295 + Ipamorelin
Peptide blend

DSIP
Sleep support peptide

Epithalon
Longevity peptide
References
- Tirzepatide - Peptide Center guide
- Tirzepatide for the Treatment of Obstructive Sleep Apnea and ObesityThe New England journal of medicine, 2024
- Tirzepatide Once Weekly for the Treatment of ObesityThe New England journal of medicine, 2022
- Tirzepatide for Obesity Treatment and Diabetes PreventionThe New England journal of medicine, 2025
- Tirzepatide as Compared with Semaglutide for the Treatment of ObesityThe New England journal of medicine, 2025
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesThe New England journal of medicine, 2021
- Tirzepatide for Heart Failure with Preserved Ejection Fraction and ObesityThe New England journal of medicine, 2025
